Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

FSD Pharma Inc C.HUGE

Alternate Symbol(s):  HUGE

FSD Pharma Inc. is a Canada-based biotechnology company. The Company operates through two segments: Biotechnology and Strategic Investments. Its Biotechnology segment is focused on furthering the research and development of the Company’s two primary drug candidates consisting of Lucid-MS and Lucid-PSYCH, as well as the development of UNBUZZD. The Company’s Strategic Investments segment is focused on generating returns and cashflow through the issuance of loans secured by residential or commercial real estate property. Lucid-PSYCH is a molecular compound identified for the potential treatment of mental health disorders. Lucid-MS is a molecular compound identified for the potential treatment of neurodegenerative disorders. UNBUZZD is a proprietary formulation of natural ingredients, vitamins, and minerals to help with liver and brain function for the purposes of potentially quickly relieving from the effects of alcohol consumption, such as inebriation, and restoring normal lifestyle.


CSE:HUGE - Post by User

Comment by JAKPUG4LIFEon Aug 31, 2020 9:54am
85 Views
Post# 31478740

RE:RE:RE:RE:Opinion on Insider Purchases

RE:RE:RE:RE:Opinion on Insider Purchasesthe Board of Directors has authorized the issuance of an additional 369,255 class B subordinate voting shares ("Class B Shares") to certain of the Company's directors, officers, employees and consultants as share-based compensation.............. Another Bonus??? I assume this is not the 5 mill they put in? Someone else have an idea on that. More dilution
Bigmac4000 wrote: Ugh. Forgot about those articles. I remember people quoting them and good ol Leonard freaking on people saying alpha is just trashing and they don't know what they are talking about, they are jealous and they are just trying to pump other stock don't listen lol. I just want this to climb to $5 canadian before they announce phase 2a. I have a theory on a bump in news. 5-6$ before the news would be nice lol. I'm curious about the way they retired / forfeited the license. My gut says they bought all those shares to keep the company afloat but thought I would get opinions from you guys and nobody disappointed lol. Consensus is to save them and get their money back in (bonus) shares they'll just cash in. They were all paid in advance in March plus bonuses. If something happens in the next week with the building sale it'll explain the panic forfeited of license otherwise it was just a panic to cut costs. Hoping for sale. Lol. I know I'm sounding like a forward thinking pumper. I'm just fed up. Willing to cut my losses if the false bump is good enough
GrahamB wrote:
Renofund wrote:
GrahamB wrote:

Catching up, and enjoying summer and minimizing time on the computer which turns out to be a very very good thing.

 

Behind on the company, but I did read with interest the posts from Big Mac and others about The Insider purchases.

 

Usually, Insider purchases can be very important, because they can indicate that Insiders who presumably have much more knowledge the company workings than us, putting Capital to work, maybe a positive sign and positive for the company.(Although if there is news coming-that would be insider knowledge so I dont believe thois to be the reason for the purchases)

 

In this case, my conclusion, and it is my conclusion only, is that this is a necessary investment to keep the company alive, and It may even be necessary if they're going to encourage other institutional investors to put in significant amount of capital.

 

Why do I say this?

 

Rather than speculate about intentions, particularly in view of the past record here(quiet period, licence, sales…), I just look at the facts, importantly and specifically, at the company facts as posted on the recent financials

 

Bottom line they had a loss of 16 million, cash of 13 million, and STILL NEED 10-30+ million for the clinical trials…

The  purchases by multiple insiders at the same time suggests it was coordinated. (again my opinion/speculation)

 

Heres the facts…

 

 

Assets-29,354,002 

BUT. …..This includes building held for sale 11,922,750 (that is a illiquid investment)

 

So look at current assets

But  CASH is 13,388,102 

 

 

Need to look at the Cash Flow statement-to see behind the scenes

 

“Cash flows used in continuing operating activities for the six months ended June 30, 2020 were $11,489,236  and net loss (16,064,683) 

...change is due to proceeds from sale of investments of $8,470,524 

Cash flow provided by financing activities for the six months ended June 30, 2020 were $9,236,210 compared to cash flows “

 

Don’t forget about contingencies for legal matters coming up. And claims from suppliers(A dismissed contractor commenced a lien action combined with a breach of contract action in the Cobourg Superior Court of Justice in early 2019 claiming approximately $1,700,000 and “The Company has a commitment to restore the designated heritage building on the Company’s premises “

 

Not to mention the related party expenses such as the “$947,498 to a company owned by the CEO”

 

and dont forget about, dilution expected, and result on possible impact on SP….

 

All sources quoted OTCQX.com

 

So I do not just take the companies claim listed below, as legal writing as some posters here claim.

My opinion is this was a needed cash infusion to stay alive.

 

 

 

 

“If unanticipated events occur that impact the Company’s ability to complete development of its production facilities and carrying the planned clinical trials, the Company may need to take additional measures to increase its liquidity and capital resources, including issuing debt or additional equity financing or strategically altering the business forecast and plan. In this case, there is no guarantee that the Company will obtain satisfactory financing terms or adequate financing. Failure to obtain adequate financing on satisfactory terms could have a material adverse effect on the Company’s results of operations or financial condition. “

Again all my opinion-due your own dd and consult a reputable finacial advisor befroe investing, and certainly dont listen to any posters on these boards, especially a  fool like me 
G



Yup
.  Question is - how much have they all taken out in comp and stock, and how much have they out back in?  The longer they keep it going, the more they can pay themselves out.  Simple math. 



Yup- first republic got 8 million with the listing alone-pretty hard to believe
Add to that the related transactions (which the OSC made them rereport finacials to clarify) etc and it puts  any investments in context.







<< Previous
Bullboard Posts
Next >>